Sirolimus-Coated Balloon Angioplasty for Infrainguinal Artery Disease
New England Journal of Medicine · 06.08.2026 · 395 (6) · 561-570
DOI: 10.1056/nejmoa2600360 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 06.08.2026. Verfasst von Stefano Barco und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Angioplasty, Balloon, Coated Materials, Biocompatible, Peripheral Arterial Disease, Sirolimus. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: University Hospital Zurich, University of Zurich, Concept Medical.
Abstract (Originalsprache)
BACKGROUND: Whether sirolimus-coated balloon angioplasty for infrainguinal artery disease reduces the incidence of major adverse limb events remains unknown. METHODS: In this prospective, open-label, noninferiority trial with a prespecified sequential testing strategy for superiority and blinded outcome adjudication, we randomly assigned patients with infrainguinal artery disease in a 1:1 ratio to undergo angioplasty with a sirolimus-coated balloon or with an uncoated balloon. The primary outcome was a composite of unplanned major amputation affecting the target limb or endovascular or surgical revascularization of the target lesion for critical limb ischemia within 1 year after randomization. The key secondary outcome was a composite of any unplanned amputation affecting the target limb or revascularization of the target lesion for critical or noncritical limb ischemia within 1 year after randomization. The noninferiority margin was 5 percentage points. The primary safety outcome was death from any cause within 1 year after randomization. RESULTS: A total of 1252 patients were enrolled in the trial: 626 patients were assigned to the sirolimus-coated-balloon group and 626 to the uncoated-balloon group. The median age of the patients was 75 years, and 35.1% were women. A primary-outcome event occurred in 55 patients (8.8%) in the sirolimus-coated-balloon group and in 94 patients (15.0%) in the uncoated-balloon group (median unbiased estimate of risk difference, -4.9 percentage points; 95% confidence interval [CI], -8.5 to -1.3; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Vascular Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
- Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
- Division of Angiology, Hôpital Universitaire et Cantonal, Fribourg, Switzerland.
- Faculty of Science and Medicine, University of Fribourg, Switzerland.
- Department of Biostatistics at the Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
- Department of Internal Medicine, Zurich Regional Health Center Wetzikon, Zurich, Switzerland.
ORCID-Profile: Stefano Barco, Simon Wolf, Tobias Tritschler
Förderung
- University Hospital Zurich
- University of Zurich
- Concept Medical
Zitieren
APA
Barco, S., Engelberger, R. P., Held, U., Fumagalli, R. M., Grigorean, A., Hayoz, D., Münger, M., Sebastian, T., Stadler, R., Voci, D., Wolf, S., Baumann, F., Tritschler, T., von Stempel, C., Périard, D., Kucher, N., & SirPAD Investigators (2026). Sirolimus-Coated Balloon Angioplasty for Infrainguinal Artery Disease. New England Journal of Medicine, 395(6), 561-570. https://doi.org/10.1056/nejmoa2600360
Vancouver
Barco S, Engelberger RP, Held U, Fumagalli RM, Grigorean A, Hayoz D, et al. Sirolimus-Coated Balloon Angioplasty for Infrainguinal Artery Disease. New England Journal of Medicine. 2026;395(6):561-570. doi:10.1056/nejmoa2600360
BibTeX
@article{Barco2026,
author = {Barco, Stefano and Engelberger, Rolf P and Held, Ulrike and Fumagalli, Riccardo M and Grigorean, Alexandru and Hayoz, Daniel and Münger, Mario and Sebastian, Tim and Stadler, Roman and Voci, Davide and Wolf, Simon and Baumann, Frédéric and Tritschler, Tobias and von Stempel, Conrad and Périard, Daniel and Kucher, Nils and SirPAD Investigators, SirPAD Investigators},
title = {Sirolimus-Coated Balloon Angioplasty for Infrainguinal Artery Disease},
journal = {New England Journal of Medicine},
year = {2026},
volume = {395},
number = {6},
pages = {561--570},
doi = {10.1056/nejmoa2600360}
}
EUVIMED